Menu
Search
|

Menu

Close
X

Bristol-Myers Squibb Co BMY.N (New York Stock Exchange)

67.95 USD
+2.01 (+3.05%)
As of 2:30 AM IST
chart
Previous Close 65.94
Open 66.17
Volume 1,629,011
3m Avg Volume 1,775,928
Today’s High 68.03
Today’s Low 66.17
52 Week High 70.04
52 Week Low 51.56
Shares Outstanding (mil) 1,639.93
Market Capitalization (mil) 106,283.60
Forward P/E 23.62
Dividend (Yield %) 0.39 ( 2.41 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.35 Mean rating from 23 analysts

KEY STATS

Revenue (mm, USD)
FY17
20,776
FY16
19,427
FY15
16,560
EPS (USD)
FY17
2.360
FY16
2.653
FY15
0.932
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
23.62
32.90
Price to Sales (TTM)
vs sector
5.25
5.77
Price to Book (MRQ)
vs sector
7.23
5.41
Price to Cash Flow (TTM)
vs sector
19.77
23.42
Total Debt to Equity (MRQ)
vs sector
55.90
16.52
LT Debt to Equity (MRQ)
vs sector
47.02
12.22
Return on Investment (TTM)
vs sector
18.60
14.43
Return on Equity (TTM)
vs sector
30.97
16.13

EXECUTIVE LEADERSHIP

Giovanni Caforio
Chairman of the Board, Chief Executive Officer, Since 2017
Salary: $1,513,080.00
Bonus: $2,995,840.00
Charles Bancroft
Chief Financial Officer and Executive Vice President - Global Business Operations, Since 2016
Salary: $966,115.00
Bonus: $1,530,650.00
Louis Schmukler
President - Global Manufacturing and Supply, Since 2011
Salary: --
Bonus: --
Ann Judge
Chief Human Resource Officer, Senior Vice President, Since 2016
Salary: --
Bonus: --
Thomas Lynch
Executive Vice President, Chief Scientific Officer, Since 2017
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

345 PARK AVE
NEW YORK   NY   10154

Phone: +1212.5464000
Site: www.bms.com/

Bristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. The Company's pharmaceutical products include chemically synthesized drugs, or small molecules, and products produced from biological processes called biologics. Small molecule drugs are administered orally in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. The Company's products include Empliciti, Opdivo, Sprycel, Yervoy, Eliquis, Orencia, Baraclude, Hepatitis C Franchise, Reyataz Franchise and Sustiva Franchise. It offers products for a range of therapeutic classes, which include virology, including human immunodeficiency virus (HIV) infection; oncology; immunoscience, and cardiovascular. Its products are sold to wholesalers, retail pharmacies, hospitals, government entities and the medical profession across the world.

SPONSORED STORIES